Kamal-Yanni, Mohga Archives - Oxfam Policy & Practice

Briefing note

Harmful Side Effects: How drug companies undermine global health

18/09/2018

1 documents

24 pages long

Languages: English

Keywords

Overview

New Oxfam research shows that four pharmaceutical companies – Abbott, Johnson & Johnson, Merck and Pfizer – systematically hide their profits in overseas tax havens. They appear to deprive developing countries of more than $100m (around £80m) every year – money that is urgently needed to meet the health needs of people in these countries […]

View resource

Technical briefing

Report of the UN Secretary-General’s High-Level Panel on human rights and medicines: Oxfam’s response

14/09/2016

1 documents

10 pages long

Languages: English

Keywords

Overview

In December 2015, the UN Secretary-General set up a High-Level Panel on Access to Medicines to ‘recommend solutions for remedying the policy incoherence between the justifiable rights of inventors, international human rights law, trade rules and public health in the context of health technologies’. Oxfam International Executive Director Winnie Byanyima is one of the 16 […]

View resource

Briefing paper

Never Again: Building resilient health systems and learning from the Ebola crisis

16/04/2015

4 documents

40 pages long

Languages: English, French

Keywords

Overview

It took the threat of a global health crisis to illustrate the failings of Africa’s health systems. Resilient health systems, free at the point of use, are evidently a global public good. They are essential for the provision of universal health coverage and for a prompt response to outbreaks of disease. Resilient health systems require […]

View resource

Briefing paper

Salt, Sugar, and Malaria Pills: How the Affordable Medicine Facility-malaria endangers public health

24/10/2012

4 documents

28 pages long

Languages: English, French, Spanish

Keywords

Overview

The Affordable Medicine Facility-malaria has shown no evidence that it has saved the lives of the most vulnerable or delayed drug resistance. Rather, this global subsidy has incentivised medicine sales without diagnosis and shown no evidence that it has served poor people. It poses a risk to public health and could skew investment away from […]

View resource

Briefing paper

Ending the R&D Crisis in Public Health: Promoting pro-poor medical innovation

13/11/2008

6 documents

50 pages long

Languages: English, French, German, Spanish

Keywords

Access to medicines

Overview

Diseases that disproportionately affect the developing world cause immense suffering and ill health. Medical innovation has the potential to deliver new medicines, vaccines, and diagnostics to overcome these diseases, yet few treatments have emerged. Current efforts to resolve the crisis are inadequate: financing for research and development (R&D) is insufficient, uncoordinated, and mostly tied to […]

View resource

Briefing paper

Patents Versus Patients: Five years after the Doha Declaration

14/11/2006

8 documents

Languages: Arabic, English, French, German, Spanish

Keywords

Overview

Five years ago, members of the World Trade Organisation (WTO) signed a ministerial agreement to ensure that intellectual property rules would no longer obstruct developing countries’ efforts to protect public health. Since then, however, little has changed. Patented medicines continue to be priced out of reach for the world’s poorest people. Trade rules remain a […]

View resource

Journal article

Introduction

01/03/2006

10 pages long

Free access through journal website

Keywords

Overview

This article does not have a description. This article is hosted by our co-publisher Taylor & Francis. For the full table of contents for this and previous issues of this journal, please visit the Gender and Development website.

View resource

Briefing note

Free Trade Agreement Between the USA and Thailand Threatens Access to HIV/AIDS Treatment

12/07/2004

1 documents

11 pages long

Languages: English

Keywords

Overview

Access to HIV/AIDS medicines makes a huge difference to the lives of infected people and their families. Not only do these medicines help people live longer, they also greatly improve the quality of their lives, reduce the stigma and discrimination that they might experience, and enable them to contribute to the economic and social welfare […]

View resource

Briefing paper

The Cost of Childbirth: How women are paying the price for broken promises on aid

01/03/2004

1 documents

30 pages long

Languages: English

Keywords

Overview

One women dies every minute as a result of problems in pregnancy or childbirth. The vast majority of these deaths are avoidable. Yet on current trends the international target of reducing maternal deaths by three-quarters by 2015 will be missed. Northern governments could transform the prospects of reaching the target by increasing the aid that […]

View resource

Journal article

Gender, poverty, and intergenerational vulnerability to HIV/AIDS

01/11/2002

8 pages long

Free access through journal website

Gender, poverty, and intergenerational vulnerability to HIV/AIDS

Keywords

Overview

This article examines how poverty and inequality increase girls’ vulnerability to HIV, and affect the ability of older women to care for AIDS sufferers. It outlines the responses of health providers and development organisations to the crisis, and recommends that gender and age analysis be integrated into health and development policy and practice. This article […]

View resource

Kamal-Yanni, Mohga

Filter Resources by